Research Article

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients

Table 1

Descriptive statistics for the first cutaneous melanoma (CM 1).

Males (%)Females (%)Total (%)

Tumour invasiveness
 In situ6 (6.7)15 (14.4)21 (10.8)
 Invasive75 (83.3)83 (79.8)158 (81.4)
 Metastasisa9 (10.0)6 (5.8)15 (7.7)
Localization
 Head/neck14 (15.6)12 (11.5)26 (13.4)
 Trunk38 (42.4)40 (38.5)78 (40.2)
 Proximal extremities10 (11.1)11 (10.6)21 (10.8)
 Distal extremities19 (21.1)35 (33.7)54 (27.8)
 Unknown primary9 (10.0)6 (5.8)15 (7.7)
Histological type
 SSMb54 (60.0)70 (67.3)124 (63.9)
 NMc10 (11.1)6 (5.8)16 (8.2)
 LMMd5 (5.6)8 (7.7)13 (6.7)
 ALMe3 (3.3)1 (1.0)4 (2.1)
 AMMf1 (1.1)1 (1.0)2 (1.0)
 Spitzoid melanoma1 (1.1)01 (0.5)
 STUMPg1 (1.1)1 (1.0)2 (1.0)
 Melanoma, not specified6 (6.7)11 (10.6)17 (8.8)
 Unknown primary9 (10.0)6 (5.8)15 (7.7)
Breslow tumour thickness (mm)
1.0144 (54.3)70 (71.4)114 (63.7)
 1.01–2.0017 (21.0)18 (18.4)35 (19.6)
 2.01–4.0011 (13.6)7 (7.1)18 (10.1)
4.009 (11.1)3 (3.1)12 (6.7)
Clark invasiveness
 I6 (8.5)15 (17.6)21 (13.5)
 II20 (28.2)25 (29.4)45 (28.8)
 III19 (26.8)21 (24.7)40 (25.6)
 IV23 (32.4)21 (24.7)44 (28.2)
 V3 (4.2)3 (3.5)6 (3.8)

aUnknown primary melanoma; bsuperficial spreading melanoma; cnodular melanoma; dlentigo maligna melanoma; eacral-lentiginous melanoma; famelanotic malignant melanoma; gspitzoid tumour of unknown malignant potency.